Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback